SFM

Sphera Funds Management Portfolio holdings

AUM $382M
This Quarter Return
+6.95%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$278M
AUM Growth
Cap. Flow
+$278M
Cap. Flow %
100%
Top 10 Hldgs %
46.19%
Holding
91
New
87
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 55.16%
2 Consumer Discretionary 5.6%
3 Technology 4.75%
4 Industrials 4.55%
5 Consumer Staples 2.45%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
JNJ icon
76
Johnson & Johnson
JNJ
$429B
$714K 0.2%
+7,800
New +$714K
ENTA icon
77
Enanta Pharmaceuticals
ENTA
$189M
$690K 0.19%
+25,292
New +$690K
RIGL icon
78
Rigel Pharmaceuticals
RIGL
$710M
$653K 0.18%
+229,100
New +$653K
ARQL
79
DELISTED
Arqule Inc
ARQL
$626K 0.17%
+291,100
New +$626K
ACHV icon
80
Achieve Life Sciences
ACHV
$146M
$618K 0.17%
+74,100
New +$618K
HSTO
81
DELISTED
Histogen Inc. Common Stock
HSTO
$565K 0.16%
+87,600
New +$565K
XNPT
82
DELISTED
XENOPORT, INC.
XNPT
$518K 0.14%
+90,000
New +$518K
GERN icon
83
Geron
GERN
$893M
$474K 0.13%
+100,000
New +$474K
ARWR icon
84
Arrowhead Research
ARWR
$3.84B
$217K 0.06%
+20,000
New +$217K
OCRX
85
DELISTED
Ocera Therapeutics, Inc.
OCRX
$193K 0.05%
+14,881
New +$193K
PTX
86
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$142K 0.04%
+56,500
New +$142K
MDGL icon
87
Madrigal Pharmaceuticals
MDGL
$9.7B
0
SODA
88
DELISTED
SodaStream International Ltd
SODA
0
MACK
89
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
0